FDA.reportPublic FDA data

Phesgo 600 MG / 600 MG / 20,000 UNT per 10 ML Injection

RxCUI
2383307
RxNorm name
Phesgo 600 MG / 600 MG / 20,000 UNT per 10 ML Injection
Display name
Phesgo 600 MG / 600 MG / 20,000 UNT per 10 ML Injection
Full name
Phesgo 600 MG / 600 MG / 20,000 UNT per 10 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:51

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761170Phesgopertuzumab, trastuzumab, and hyaluronidase-zzxf351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
27dd5e6b-72cd-458d-a015-cf4dab5800daPhesgo 600 MG / 600 MG / 20,000 UNT in 10 mL Injection [PSN] · 10 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 60 MG/ML / trastuzumab-zzxf 60 MG/ML Injection [Phesgo] [SBD] · Phesgo 600 MG / 600 MG / 20,000 UNT per 10 ML Injection [SY]317These highlights do not include all the information needed to use PHESGO safely and effectively. See full prescribing information for PHESGO. PHESGO ® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) injection, for subcutaneous use Initial U.S. Approval: 202020260521